These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8983889)

  • 1. Meropenem permeation through the outer membrane of Pseudomonas aeruginosa can involve pathways other than the OprD porin channel.
    Pérez FJ; Gimeno C; Navarro D; García-de-Lomas J
    Chemotherapy; 1996; 42(3):210-14. PubMed ID: 8983889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Pseudomonas aeruginosa isolates to ceftazidime is unrelated to the expression of the outer membrane protein OprC.
    Pérez FJ; Navarro D; Gimeno C; García-de-Lomas J
    Chemotherapy; 1997; 43(1):27-30. PubMed ID: 8996738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates.
    Naenna P; Noisumdaeng P; Pongpech P; Tribuddharat C
    Southeast Asian J Trop Med Public Health; 2010 May; 41(3):614-24. PubMed ID: 20578550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem.
    Epp SF; Köhler T; Plésiat P; Michéa-Hamzehpour M; Frey J; Pechère JC
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1780-7. PubMed ID: 11353625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between outer membrane protein profiles and resistance to ceftazidime, imipenem, and ciprofloxacin in Pseudomonas aeruginosa isolates from bacteremic patients.
    Gimeno C; Navarro D; Savall F; Millás E; Farga MA; Garau J; Cisterna R; García-de-Lomas J
    Eur J Clin Microbiol Infect Dis; 1996 Jan; 15(1):82-5. PubMed ID: 8641311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
    El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
    APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem.
    Farra A; Islam S; Strålfors A; Sörberg M; Wretlind B
    Int J Antimicrob Agents; 2008 May; 31(5):427-33. PubMed ID: 18375104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane.
    Fukuoka T; Ohya S; Narita T; Katsuta M; Iijima M; Masuda N; Yasuda H; Trias J; Nikaido H
    Antimicrob Agents Chemother; 1993 Feb; 37(2):322-7. PubMed ID: 8452364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of specific surface loop regions in determining the function of the imipenem-specific pore protein OprD of Pseudomonas aeruginosa.
    Huang H; Hancock RE
    J Bacteriol; 1996 Jun; 178(11):3085-90. PubMed ID: 8655484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids.
    Ochs MM; McCusker MP; Bains M; Hancock RE
    Antimicrob Agents Chemother; 1999 May; 43(5):1085-90. PubMed ID: 10223918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level resistance to meropenem in clinical isolates of Pseudomonas aeruginosa in the absence of carbapenemases: role of active efflux and porin alterations.
    Chalhoub H; Sáenz Y; Rodriguez-Villalobos H; Denis O; Kahl BC; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2016 Dec; 48(6):740-743. PubMed ID: 28128097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
    Lee JY; Ko KS
    Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
    Chen HY; Livermore DM
    J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of basic amino acids on susceptibility to carbapenems in clinical Pseudomonas aeruginosa isolates.
    Muramatsu H; Horii T; Morita M; Hashimoto H; Kanno T; Maekawa M
    Int J Med Microbiol; 2003 Jun; 293(2-3):191-7. PubMed ID: 12868655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
    Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
    J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of carbapenems on the transcriptional expression of the oprD, oprM and oprN genes in Pseudomonas aeruginosa.
    Kolayli F; Karadenizli A; Savli H; Ergen K; Hatirnaz O; Balikci E; Budak F; Vahaboglu H
    J Med Microbiol; 2004 Sep; 53(Pt 9):915-920. PubMed ID: 15314200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of Pseudomonas aeruginosa to imipenem induced by eluates from siliconized latex urinary catheters is related to outer membrane protein alterations.
    Martínez-Martínez L; Pascual A; Conejo MC; Picabea L; Perea EJ
    Antimicrob Agents Chemother; 1999 Feb; 43(2):397-9. PubMed ID: 9925543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic definition of the substrate selectivity of outer membrane porin protein OprD of Pseudomonas aeruginosa.
    Huang H; Hancock RE
    J Bacteriol; 1993 Dec; 175(24):7793-800. PubMed ID: 8253668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Penetration of meropenem in gram-negative bacilli. Differences in activity with imipenem].
    García de Lomas J; Navarro D; Gimeno C
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():14-9. PubMed ID: 9410063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa.
    Shibata K; Adachi Y; Kato E; Nagano R; Fuse A; Hashizume T; Ohtake N; Okamoto O; Nakagawa S
    J Antibiot (Tokyo); 1997 Feb; 50(2):135-8. PubMed ID: 9099222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.